Bruce Ross Winson insider trades: MEI Pharma (MEIP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bruce reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | MEIP | ↑ Buy | 48,060 | $6.85 | $329K | Indirect | Sep 25, 2023 (3d) |
| Sep 21, 2023 | MEIP | ↑ Buy | 153,600 | $6.11 | $938K | Indirect | Sep 22, 2023 (1d) |
| Nov 8, 2017 | SCOO | ↓ Sell | 800,000 | $16.55 | $13.2M | Indirect | Nov 9, 2017 (1d) |
| Nov 22, 2016 | SCOO | ↑ Buy | 71,083 | $87.00 | $6.2M | Indirect | Nov 25, 2016 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bruce Ross Winson's insider trades
Bruce Ross Winson is a 10% owner of MEI Pharma (MEIP). Since Nov 22, 2016, Bruce has reported 3 open-market purchases worth $7.5M and 1 sale worth $13.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.